Adriana Tajonar

Vice President of Life Sciences Investing at Goldman Sachs

San Francisco, California

Overview 

Adriana Tajonar is the Vice President of Life Sciences Investing at Goldman Sachs in San Francisco, California. With a PhD from Harvard University and a B.S. from Massachusetts Institute of Technology, she has held key roles at leading biotech companies like Insitro and has served on the boards of A2 Biotherapeutics, Inc. and Carmot Therapeutics.

Work Experience 

  • Vice President

    2022 - Current

Goldman Sachs is a multinational financial services firm providing securities, investment banking, and management services.

  • Head of External Innovation

    2020 - 2022

Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.

Raised $643,000,000.00 from Alexandria Venture Investments, BlackRock, HOF Capital, CPP Investments, Google Ventures, Foresite Capital, Casdin Capital, Temasek Holdings, T. Rowe Price and Third Rock Ventures.

  • Board Member

    2018 - 2020

  • Board Observer

    2017 - 2020

Accent Therapeutics is a biopharmaceutical company.

Raised $178,000,000.00 from Bristol-Myers Squibb, Atlas Venture, NS Investment, Mirae Asset Venture Investment, EcoR1 Capital, Mirae Asset Capital, The Mark Foundation for Cancer Research, Droia Ventures, The Column Group and Mirae Asset Capital Life Science.

  • Board Member

    2017 - 2020

  • Principal

    2017 - 2020

  • Associate

    2015 - 2016

  • Partner

    2014 - 2015

  • Entrepreneurship Program Manager

    2013 - 2015

    Mentoring and supporting the most promising life science startups in California. 1. QB3 Startup in a Box Program and QB3/BayBio Accelerator Program o Leading the programs aimed at forming well-structured life science startup companies, preparing them for SBIR funding, coaching them on delivering compelling pitch presentations, and advising for an efficient transition into operations. o Mentoring and incorporating over 180 companies in the areas of therapeutics, diagnostics, medical devices, and synthetic biology. o Launching an online platform for mentoring and peer learning for entrepreneurs. 2. Mission Bay Capital o Identifying pre-commercial scientific opportunities for seed investment by Mission Bay Capital, a QB3-managed seed-stage venture fund. 3. QB3 Rosenman Institute o Helping define vision and operational strategy as a founding team member of the Rosenman Institute, QB3’s new initiative to accelerate the development of medical devices in collaboration with UCSF’s Department of Surgery and experienced medical device engineers. 4. General o Matching QB3 startups with Pharma and Healthcare Partners o Identifying new programs and workshops to increase the education of life-science entrepreneurs. o Building program partnerships with industry experts, entrepreneurs, and service providers. o Marketing QB3 programs to life science researchers, entrepreneurs, international partners, and sponsors.

  • Interim Entrepreneurship Program Manager

    2012 - 2013

  • Intern

    2012 - 2012

    • Contributed to building the QB3 Accelerator program to increase the operational excellence of startup companies in the San Francisco Bay Area. • Organized efficient and strategic to-do lists and Gantt charts for startup companies. • Contacted industry partners to build a network of Bay Area companies and entrepreneurs.

  • Teaching Assistant for Life Science Lean LaunchPad course

    2013 - 2013

    Inaugural Life Science Lean LaunchPad class was taught by Steve Blank along with 4 renowned venture capitalists in the areas of Therapeutics, Diagnostics, Medical Devices, and Digital Health. • Guided teams in the Therapeutics cohort in discovering their product-market fit. • Provided feedback and guidance on customer interviews to define team strategy.

  • Doctoral Candidate

    2006 - 2012

    - Carried out a genetic gain-of-function screen to find new regulators of human embryonic stem (hES) cell maintenance. - Identified and characterized a novel gene that promotes survival in hES cells.

  • Teaching Assistant for Human Developmental and Regenerative Biology

    2009 - 2011

    Organized weekly discussion sections and review sessions, wrote and graded exams and problem sets for three courses led by Principal Faculty in the Department of Stem Cell and Regenerative Biology: - SCRB 165 - Directed Differentiation of Stem Cells - SCRB 10 - Human Developmental and Regenerative Biology - SCRB 140 - Molecular Mechanisms of Growth and Regeneration Earned outstanding student review scores in all courses and a distinction in teaching for SCRB 10.

Articles About Adriana

Relevant Websites